These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1627 related items for PubMed ID: 11268324

  • 21. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
    Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Bénard A, Bordigoni P, Gandemer V, Thuret I, Dalle JH, Piguet C, Pautard B, Baruchel A, Leverger G, French Society of Pediatric Hematology and Immunology.
    J Clin Oncol; 2003 Dec 01; 21(23):4377-85. PubMed ID: 14645428
    [Abstract] [Full Text] [Related]

  • 22. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 01; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 23. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
    Woessmann W, Peters C, Lenhard M, Burkhardt B, Sykora KW, Dilloo D, Kremens B, Lang P, Führer M, Kühne T, Parwaresch R, Ebell W, Reiter A.
    Br J Haematol; 2006 Apr 01; 133(2):176-82. PubMed ID: 16611309
    [Abstract] [Full Text] [Related]

  • 24. Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study.
    Sandler ES, Homans A, Mandell L, Amylon M, Wall DA, Devidas M, Buchanan GR, Lipton JM, Billett AL.
    J Pediatr Hematol Oncol; 2006 Apr 01; 28(4):210-5. PubMed ID: 16679917
    [Abstract] [Full Text] [Related]

  • 25. Outcome of very late relapse in children with acute lymphoblastic leukemia.
    Rizzari C, Valsecchi MG, Aricò M, Miniero R, Messina C, De Rossi G, Testi AM, Mura R, Galimberti S, Biondi A, Locatelli F, Conter V.
    Haematologica; 2004 Apr 01; 89(4):427-34. PubMed ID: 15075076
    [Abstract] [Full Text] [Related]

  • 26. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients].
    Jin FY, Zou DH, Wang GR, Xu Y, Feng SZ, Zhao YZ, Han MZ, Yan WW, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov 01; 26(11):645-8. PubMed ID: 16620547
    [Abstract] [Full Text] [Related]

  • 27. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):111-7. PubMed ID: 8832003
    [Abstract] [Full Text] [Related]

  • 28. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B, Peters C, Ebell W, Zimmermann M, Niggli F, Ludwig WD, Riehm H, Welte K, Schrappe M.
    J Clin Oncol; 2006 Dec 20; 24(36):5742-9. PubMed ID: 17179108
    [Abstract] [Full Text] [Related]

  • 29. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1289-94. PubMed ID: 19731318
    [Abstract] [Full Text] [Related]

  • 30. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.
    Dudler C, Bargetzi M, Tichelli A, Gratwohl A, Passweg JR, Wernli M.
    Eur J Haematol; 2009 Dec 01; 83(6):512-8. PubMed ID: 19614953
    [Abstract] [Full Text] [Related]

  • 31. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.
    Saarinen-Pihkala UM, Heilmann C, Winiarski J, Glomstein A, Abrahamsson J, Arvidson J, Békássy AN, Forestier E, Jonmundsson G, Schroeder H, Vettenranta K, Wesenberg F, Gustafsson G.
    J Clin Oncol; 2006 Dec 20; 24(36):5750-62. PubMed ID: 17179109
    [Abstract] [Full Text] [Related]

  • 32. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
    Houtenbos I, Bracho F, Davenport V, Slack R, van de Ven C, Suen Y, Killen R, Shen V, Cairo MS.
    Bone Marrow Transplant; 2001 Jan 20; 27(2):145-53. PubMed ID: 11281383
    [Abstract] [Full Text] [Related]

  • 33. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML, Langston A, Winton E, Flowers CR, Waller EK.
    Biol Blood Marrow Transplant; 2007 Jan 20; 13(1):116-23. PubMed ID: 17222760
    [Abstract] [Full Text] [Related]

  • 34. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 20; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 35. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M, Reiter A, Sauter S, Ludwig WD, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E.
    Klin Padiatr; 1994 May 20; 206(4):208-21. PubMed ID: 7526027
    [Abstract] [Full Text] [Related]

  • 36. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E, Klingebiel TH, Peters C, Hermann J, Burdach ST, Bender-Götze C, Müller-Weihrich ST, Treuner J.
    Bone Marrow Transplant; 1997 Feb 20; 19(3):227-31. PubMed ID: 9028550
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora KW, Holter W, Kabisch H, Klingebiel T, von Stackelberg A, ALL-REZ BFM Study Group.
    J Clin Oncol; 2009 Jan 20; 27(3):377-84. PubMed ID: 19064980
    [Abstract] [Full Text] [Related]

  • 38. [Bone marrow relapse in high-risk pediatric patients with acute lymphoblastic leukemia: a comparison of relapse times and initial clinical features of patients on different protocols. Children's Cancer and Leukemia Study group (CCLSG)].
    Tsurusawa M, Katano N, Hirota T, Koizumi S, Asami K, Chin M, Ota S, Kawakami T, Hatae Y, Sekine I, Iwai A, Anami K, Nishi K, Miyake M, Watanabe A, Yatabe M, Kawakami K, Gushi K, Yokota S, Gusiken T, Kikuta A, Mimaya J, Okada N, Iga M, Fujimoto T.
    Rinsho Ketsueki; 1998 Aug 20; 39(8):565-73. PubMed ID: 9785974
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
    IMAHASHI N, TOKUNAGA M, NISHIWAKI S, YANAGISAWA M, OZAWA Y, MIYAMURA K.
    Rinsho Ketsueki; 2009 Nov 20; 50(11):1612-5. PubMed ID: 20009435
    [Abstract] [Full Text] [Related]

  • 40. Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on).
    Torres A, Alvarez MA, Sánchez J, Flores R, Martinez F, Gómez P, Rojas R, Herrera C, García JM, Andrés P, Velasco F, Serrano J, Román J, Rodriguez A, Martin C, Tabares S, Rodriguez JM, Parody R, Plaza E, León A, Romero R, Jean-Paul E, Prados D, Aljama R, Fernández A.
    Bone Marrow Transplant; 1999 Jun 20; 23(12):1257-60. PubMed ID: 10414912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 82.